SCHEMBL4565984

SCHEMBL4565984

CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2)c(C(=O)O)c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.85
AGTR1 P30556 4/20 0.85
AGTR2 P50052 2/20 0.85
KDM4E B2RXH2 1/20 0.85
ABCC3 O15438 1/20 0.85
ABCC4 O15439 1/20 0.85
USP2 O75604 1/20 0.85
ABCB11 O95342 1/20 0.85
ALDH1A1 P00352 1/20 0.85
CHRM2 P08172 1/20 0.85
CYP3A4 P08684 1/20 0.85
ADRA2A P08913 1/20 0.85
ADORA3 P0DMS8 1/20 0.85
CHRM1 P11229 1/20 0.85
CYP2C9 P11712 1/20 0.85
ACE P12821 1/20 0.85
ADRA2C P18825 1/20 0.85
TBXA2R P21731 1/20 0.85
GLRA1 P23415 1/20 0.85
PDE4A P27815 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29377244 1.00 PPARG (0.85) PPARGAGTR1AGTR2KDM4EABCC3
SCHEMBL28397323 0.94 PPARG (0.84) PPARGAGTR1AGTR2KDM4EABCC3
SCHEMBL6080037 0.92 AGTR1 (0.75) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL29356790 0.92 AGTR1 (1.00) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL29414101 0.92 AGTR1 (1.00) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL2122886 0.92 AGTR1 (1.00) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL29691699 0.92 AGTR1 (1.00) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL4464 0.92 AGTR1 (1.00) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL3384004 0.91 AGTR1 (0.98) PPARGAGTR1AGTR2KDM4EABCC3
Telmisartan SCHEMBL998659 0.91 AGTR1 (0.98) PPARGAGTR1AGTR2KDM4EABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111053910-A Composition comprising fatty acid or derivative thereof and disubstituted biphenyl derivative 黄泳华 2020-04-24 CN claimed
EP-1393722-A2 Use of angiotensin II subtype 1 (AT1) antagonists for the manufacture of a medicament in the treatment of premenstrual syndrome DePadova, Anthony S. (US) 2004-03-03 EP claimed
CN-116675648-A Preparation method of telmisartan 迪嘉药业集团股份有限公司 2023-09-01 CN disclosed
CN-114573513-B Synthesis method of telmisartan intermediate 济南大学 2023-05-16 CN disclosed
CN-114573513-A Synthesis method of telmisartan intermediate 济南大学 2022-06-03 CN disclosed
CN-110934848-B Telmisartan capsule and preparation method thereof 江西杏林白马药业股份有限公司 2022-02-15 CN disclosed
CN-111053910-A Composition comprising fatty acid or derivative thereof and disubstituted biphenyl derivative 黄泳华 2020-04-24 CN disclosed
CN-110934848-A Telmisartan capsule and preparation method thereof 江西杏林白马药业有限公司 2020-03-31 CN disclosed
EP-2046756-A2 PREPARATION OF TELMISARTAN SALTS Krka Tovarna Zdravil, D.D., Novo Mesto (SI) 2009-04-15 EP disclosed
EP-1912975-A1 A PROCESS FOR THE PREPARATION OF TELMISARTAN Matrix Laboratories Ltd (IN) 2008-04-23 EP disclosed
WO-2007147889-A2 PREPARATION OF TELMISARTAN SALTS KRKA, TOVARNA ZDRAVIL, D.D., NOVO MESTO (SI) 2007-12-27 WO disclosed
WO-2007028524-A2 USE OF A DERIVATIVE OF IMIDAZOLE FOR THE TREATMENT OF LEUKOTRIENE RELATED DISORDERS PROUS INSTITUTE FOR BIOMEDICAL RESEARCH S.A. (ES) 2007-03-15 WO disclosed
WO-2007010558-A1 A PROCESS FOR THE PREPARATION OF TELMISARTAN MATRIX LABORATORIES LIMITED (IN) 2007-01-25 WO disclosed
EP-1313468-A2 PHARMACEUTICAL COMBINATION OF ANGIOTENSIN II ANTAGONISTS AND ACE INHIBITORS Boehringer Ingelheim Pharma KG (DE) 2003-05-28 EP disclosed
WO-2002015891-A2 PHARMACEUTICAL COMBINATION OF ANGIOTENSIN II ANTAGONISTS AND ACE INHIBITORS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2002-02-28 WO disclosed